• Cediranib (AZD2171): Precision Angiogenesis Inhibition in Ca

  2026-06-26

  Cediranib (AZD2171) stands out as a highly potent, multi-kinase angiogenesis inhibitor, enabling nuanced dissection of VEGFR signaling and PI3K/Akt/mTOR pathway modulation. This article delivers practical workflows, troubleshooting insights, and evidence-based protocol enhancements to maximize data reproducibility and translational value in preclinical cancer research.

• Recombinant Human IL-15: Immune Circuitry, Assays, and Neuro

  2026-06-26

  Explore the multifaceted roles of Recombinant Human IL-15 in immune cell activation, advanced proliferation assays, and its unique relevance to neurobehavioral research. This article offers in-depth scientific insight distinct from existing reviews, establishing a new perspective on IL-15's application in immunology.

• Polymyxin B (Sulfate): Mechanism, Research Evidence, and Lim

  2026-06-25

  Polymyxin B (sulfate) is a validated polypeptide antibiotic for multidrug-resistant Gram-negative bacteria, with a unique membrane-disrupting mechanism. It is essential in research on bloodstream and urinary tract infections, and demonstrates immunomodulatory effects on dendritic cell maturation. Rigorous benchmarks and workflow parameters guide its optimal use in translational models.

• Morin: Protocol Advances in Disease Modeling & Bioassays

  2026-06-25

  Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) from APExBIO empowers translational research with robust anti-inflammatory, neuroprotective, and fluorescent probe capabilities. This article delivers actionable workflows, troubleshooting, and strategic insights for high-impact experimental design.

• Monomethyl Auristatin E: Precision Payloads for ADC Workflow

  2026-06-24

  Monomethyl auristatin E (MMAE) is redefining targeted cancer therapy as a high-potency antimitotic payload in antibody-drug conjugate (ADC) development. Explore stepwise workflow strategies, troubleshooting, and translational insights that maximize MMAE's performance across in vitro and in vivo oncology models.

• Bazedoxifene: Selective Estrogen Receptor Modulator in Resea

  2026-06-23

  Bazedoxifene delivers unrivaled control for estrogen receptor signaling studies, enabling precise modeling of osteoporosis and tissue-selective pharmacology. This article details experimental workflows, troubleshooting insights, and key innovations to maximize reproducibility in preclinical research.

• Salinomycin: Polyether Ionophore Antibiotic for HCC Research

  2026-06-23

  Salinomycin stands out as a powerful polyether ionophore antibiotic in hepatocellular carcinoma (HCC) research, uniquely targeting Wnt/β-catenin signaling and drug resistance pathways. This guide delivers actionable protocols, troubleshooting insights, and comparative analysis to unlock Salinomycin's full experimental potential.

• Exercise-Induced Muscle Vesicles Enhance Amyloid Clearance i

  2026-06-22

  This study uncovers a novel mechanism by which swimming exercise alleviates cognitive dysfunction in Alzheimer's disease (AD) mice. The findings reveal that skeletal muscle-derived extracellular vesicles (SKM-EVs), enriched after exercise, are taken up by microglia and promote amyloid plaque clearance, suggesting new therapeutic directions for AD.

• Recognizing Stroke Mimics: Lessons from Prochlorperazine-Ind

  2026-06-22

  The reference study presents a rare case of prochlorperazine-induced hemidystonia that closely mimicked acute ischemic stroke in a pregnant patient, highlighting the diagnostic challenges in emergency settings. This case emphasizes the need for systematic exclusion of stroke mimics before administering fibrinolytic therapy and provides practical insight into protocol optimization for neurologic emergencies.

• pH-Responsive i-Motif ASO Prodrugs for Targeted MYCN Silenci

  2026-06-21

  This study introduces a series of pH-responsive hairpin antisense oligonucleotide (ASO) prodrugs leveraging the i-motif structure to enable controlled release and enhanced silencing of MYCN in tumor cells. The research demonstrates how structural tuning of ASO hairpins modulates stability and release, offering a rational design strategy for tumor-microenvironment-responsive gene therapies.

• Risedronate Sodium: FPPS Inhibitor Workflows for Bone Resear

  2026-06-20

  Risedronate Sodium, a potent FPPS inhibitor, offers researchers a robust toolkit for dissecting bone metabolism and antiproliferative effects in tumor models. This guide details advanced protocols, delivery innovations, and troubleshooting strategies that maximize its impact across osteoporosis, cancer research, and pulmonary applications.

• Modified IVT-mRNA Encoding TPO Stimulates Thrombopoiesis in

  2026-06-19

  This study demonstrates that chemically modified in vitro-transcribed (IVT) mRNA encoding thrombopoietin (TPO) can robustly stimulate platelet production in mice, offering a promising approach to treat thrombocytopenia. The research highlights improved safety and efficacy over conventional protein or receptor agonist therapies, with implications for the future of mRNA-based therapeutics.

• Reliable Gene Editing with EZ Cap™ Cre mRNA (m1Ψ): Lab Scena

  2026-06-19

  This article delivers a scenario-driven examination of common laboratory challenges in Cre-lox gene editing, focusing on how EZ Cap™ Cre mRNA (m1Ψ) (SKU R1030) from APExBIO addresses workflow reproducibility, translation efficiency, and low immunogenicity. Researchers will find actionable guidance and validated parameters for optimizing cell-based assays using advanced mRNA technology.

• PXR Activation Enhances Urine Concentration via AVP Upregula

  2026-06-18

  This study demonstrates that activation of the pregnane X receptor (PXR) in the hypothalamus increases urine concentration by upregulating arginine vasopressin (AVP) expression. These findings reveal a novel neuroendocrine function for PXR, with potential implications for water homeostasis disorders.

• Applied Workflows with Verteporfin: Precision in CL 318952 A

  2026-06-18

  Verteporfin, supplied by APExBIO, is transforming photodynamic therapy and autophagy research with its dual-action profile. This guide demystifies practical protocols, highlights troubleshooting strategies, and bridges recent mechanobiology insights for next-generation cell viability and apoptosis assays.

10355 records 3/691 page Previous Next 12345 下5页 Last page